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Abstract
Background: Highly malignant gliomas are characterized by rapid growth, extensive local tissue
infiltration and the resulting overall dismal clinical outcome. Gaining any additional insights into the
complex interaction between this aggressive brain tumor and its microenvironment is therefore
critical. Currently, the standard imaging modalities to investigate the crucial interface between
tumor growth and invasion in vitro are light and confocal laser scanning microscopy. While
immensely useful in cell culture, integrating these modalities with this cancer's clinical imaging
method of choice, i.e. MRI, is a non-trivial endeavour. However, this integration is necessary,
should advanced computational modeling be able to utilize these in vitro data to eventually predict
growth behaviour in vivo. We therefore argue that employing the same imaging modality for both
the experimental setting and the clinical situation it represents should have significant value from a
data integration perspective. In this case study, we have investigated the feasibility of using a specific
form of MRI, i.e. magnetic resonance microscopy or MRM, to study the expansion dynamics of a
multicellular tumor spheroid in a collagen type I gel.
Methods:  An U87mEGFR human giloblastoma multicellular spheroid (MTS) containing
approximately 4·103 cells was generated and pipetted into a collagen I gel. The sample was then
imaged using a T2-weighted 3D spoiled gradient echo pulse sequence on a 14T MRI scanner over
a period of 12 hours with a temporal resolution of 3 hours at room temperature. Standard
histopathology was performed on the MRM sample, as well as on control samples.
Results: We were able to acquire three-dimensional MR images with a spatial resolution of 24 ×
24 × 24 μm3. Our MRM data successfully documented the volumetric growth dynamics of an MTS
in a collagen I gel over the 12-hour period. The histopathology results confirmed cell viability in the
MRM sample, yet displayed distinct patterns of cell proliferation and invasion as compared to
control.
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Conclusion: In this study, we demonstrate that a specific form of MRI, i.e. magnetic resonance
microscopy or MRM, can be used to study the dynamic growth of a multicellular tumor spheroid
(MTS) with a single cell scale spatial resolution that approaches the level of light microscopy. We
argue that MRM can be employed as a complementary non-invasive tool to characterize
microscopic MTS expansion, and thus, together with integrative computational modeling, may
allow bridging of the experimental and clinical scales more readily.
Background
High-grade malignant gliomas are characterized by rapid
volumetric growth and extensive local tissue infiltration.
Despite all efforts to improve diagnostics and therapy, the
outcome remains dismal with a five-year survival rate
below 3.3% in the main age group of 45-years and older
[1]. Since the surrounding tissue is thought to impact, per-
haps even guide the tumor's invasive patterns, much
weight is currently being put on better understanding the
dynamic interaction of an expanding brain tumor with its
microenvironment. As such, following an interdiscipli-
nary approach, we have previously employed an in vitro
glioma multicellular tumor spheroid (MTS) model to
investigate the spatial and temporal dynamics of MTS
expansion within extracellular matrix environments [2-4],
and started to model them in silico [5-7]. In these studies,
various aspects of the interaction between a growing sphe-
roid system and its environment were studied and mathe-
matically modeled, including extracellular matrix
concentration, mechanical forces, and invasion direction-
ality.
In the 1980s, several groups independently acquired
microscopic images of different biological samples using
magnetic resonance spectroscopy [8-10]. These early stud-
ies demonstrated the feasibility of magnetic resonance
microscopic imaging with its unique sensitivity to tissue
water environment. Since then, with continued advances
in magnetic resonance imaging (MRI) techniques (incl.
stronger gradient coils, improved RF coil design, and
more powerful computers), the imaging resolution has
steadily increased. We are now able to acquire three-
dimensional (3D) images at a high signal to noise ratio
with a resolution approaching the single cell level. This
allows us to employ MRI, the imaging modality of choice
in vivo, to study these microscopic tumor models also in
vitro.
We have previously reported that magnetic resonance
microscopy (MRM) enables us to distinguish an MTS of
roughly 250 μm in diameter in a collagen I gel and pro-
vides us with a true 3D view of the MTS within the matrix
[11]. However, the time required to obtain high-resolu-
tion 3D images was considerably long, typically 10 hours.
To dynamically monitor MTS growth, we would have to
increase the temporal resolution while maintaining a
comparable signal to noise ratio (SNR). For this very pur-
pose, we applied Gd-DTPA, the contrast agent widely used
in clinics, to the collagen I matrix, achieving not only a
significantly shortened MR imaging time down to 3
hours, but also increasing the SNR from 20 to over 40.
Therefore, we are able to dynamically monitor both glo-
bal and local changes of the MTS over a 12-hour period at
a temporal resolution of 3 hours and an isotropic spatial
resolution of 24 μm. Using conventional immunohisto-
chemistry techniques we were able to confirm cell viabil-
ity in the MRM sample post imaging, as well as to find
patterns of cell proliferation and invasion that seem dis-
tinctively different from the controls and thus warrant fur-
ther analyses.
In summary, we argue that MRM enables us to examine
MTS growth dynamically with a true 3D view. The nature
of MRM data allows us to segment the spheroid's contour
out of its microenvironment, reconstruct and visualize its
surface, and subsequently analyze the MTS' distinct 3D
dynamics from any selected angle. Tracking tumor expan-
sion non-invasively down to the 'single-cell' scale by using
a clinically relevant imaging modality should facilitate
data integration, and, in combination with in silico mode-
ling, will yield valuable insights into the critical interac-
tion between the tumor and its microenvironment.
Methods
Multicellular tumor spheroid (MTS) and extracellular 
matrix
Cell culture
The U87mEGFR [11-13] cell line is cultured in 10 mL of
high-glucose Dulbecco's Modified Essential Medium
(DMEM; Invitrogen, Carlsbad, CA), supplemented with
1% Penicillin-Streptomycin (PS; Invitrogen), 10% Fetal
Bovine Serum (FBS; JRH Biosciences, Lenexa, KS), 0.5 mg/
mL Geneticin (Invitrogen) and 20 mM hepes buffer (Inv-
itrogen) in 10 cm diameter Petri dishes (Corning, Corn-
ing, NY). Once cells are confluent, they are twice rinsed
with Phosphate Buffered Saline (Invitrogen) and detach
after the addition of 1 mL Trypsin-EDTA (Invitrogen).
After 5–10 min, 9 mL of fresh cell media is added to neu-
tralize the Trypsin. The cell solution is then transferred
into a 15 mL centrifuge tube and centrifuged for 5 min at
1200 RPM (~2·103 m/s2). After aspirating the superna-BMC Medical Imaging 2008, 8:3 http://www.biomedcentral.com/1471-2342/8/3
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tant, the cells are resuspended in fresh media at a concen-
tration of 2·105/mL.
Multicellular spheroids
Spheroids are then generated using the hanging droplet
method [14], with a drop size of 20 μL, which seeds
~4·103  cells in each spheroid to yield a diameter of
approximately 400 μm. Briefly, multiple droplets of 20 μL
of cell solution are pipetted onto the inside of a 100 mm-
diameter Petri dish cover. After placing the cover back on
a culture medium-filled dish, the dish itself is placed in
the incubator (5% CO2, 37°C). Surface tension maintains
droplet integrity, while gravity pulls cells together at the
bottom of each droplet. Cells are left to form spheroids in
the incubator for 3 days before they are collected.
Extracellular matrix
The extracellular matrix (ECM) model is a 1.5 mg/mL
bovine collagen type I (Inamed Biomaterials, Fremont,
CA) matrix supplemented with 10% FBS, 10% 10X Mini-
mum Essential Medium (MEM; Invitrogen), 1% PS, 50
mM sodium bicarbonate (NaHCO3; Sigma, St. Louis,
MO) buffer. For image enhancement, 10 mM Gd-DTPA
(Magnevist; Berlex, Wayne, NJ, U.S.A.) is added to the col-
lagen solution. To induce polymerization, a few μL of 1 M
sodium hydroxide (NaOH; Sigma) are added until a neu-
tral pH is reached. The choice of 1.5 mg/mL concentration
used here is based on work by Kaufman et al. [2] and rep-
resents a reasonable compromise between achieving a suf-
ficiently high viscoelastic modulus while avoiding
blocking cell motility altogether.
Sample preparation
For each sample, we pipette 280 μLs of collagen solution
into a μPCR tube (VWR, West Chester, PA). After 15–30
min in the incubator to allow the gel to initiate polymeri-
zation, a spheroid is pipetted into this collagen gel, which
is then placed back in the incubator for several hours to
allow cells to attach properly to the ECM before imaging.
To assess the impact of MRM on cell viability, we com-
pared the histology of the MR-imaged specimen with a
control group that was treated identically but for one dif-
ference: instead of being imaged overnight, it was kept in
the incubator. As soon as the experiment was halted, both
the imaged specimen and the control samples were fixed,
sectioned and stained.
Magnetic resonance microscopy
We first measured Gd-DTPA (Magnevist) relaxivity in
water at 14T (Magnex, 89 mm vertical bore, gradient
strength 100 gauss/cm, Bruker Biospin System) using the
conventional inversion recovery spin echo sequence at
three different concentrations (0.075, 2.5, 5 mM). The
Gd-DTPA concentration (10 mM) used here was then
determined based on its dosage (0.2 – 0.5 mmol/kg) in
MRI mouse model studies [15,16] and its relaxivity at 14T.
The MTS in collagen with 10 mM Gd-DTPA was imaged
using MRM at 14T. Specifically, we first used a modified
FLASH pulse sequence to acquire multi-slice multi-echo
(TR/TE = 400/3 8 13 18 ms; FOV = 0.95 cm, 256 × 256;
slice thickness = 400 μm; α = 30) images with an in-plane
resolution of 37 × 37 μm2 to localize the MTS in the colla-
gen I gel. A quick T1 measurement was then performed
using a modified IR_RARE sequence (TR/TE: 1500/7.86
ms; rare factor: 2; matrix size: 128 × 128; 10 slices with 0.4
mm slice thickness; FOV: 0.6 cm; TI: 5.621 55.620
105.620 205.620 505.620 1005.620 2005.620 ms). A
three-dimension spoiled gradient echo (FLASH) sequence
(TR/TE = 20/5.5 ms; FOV = 1.2 × 0.6 × 0.6; matrix size:
512 × 256 × 256; signal was optimized at the Ernst angle)
was then used to acquire high-resolution (24 μm iso-
tropic) microscopic images every three hours for a total of
12 hours. After imaging, the sample was fixed for his-
topathological analysis as described below. MR images
were displayed employing an ImageJ software package
[17] and then segmented using the 3D Slicer software
package [18]. T1 of the sample and Gd-DTPA relaxivity
were fitted using Matlab (Mathwork, Inc., Natick, MA).
After the MTS was manually segmented for each time
point, its corresponding volume and surface area were cal-
culated.
Histology
The spheroids were harvested and processed as described
before [4], fixed in 10% formalin and embedded in paraf-
fin. Blocks were serially sectioned in 7 μm thick sections
and stained with hematoxylin and eosin (H&E). In order
to assess the proliferative activity, immunohistochemistry
was performed by using cell cycle-unspecific MIB1 anti-
body (which detects the nuclear Ki-67 antibody so that
quiescent cells (G0) remain unstained) (DAKO, M7240,
USA; 1:50 dilution). The so called MIB-1 labeling index
was then calculated as the fraction of MIB-1 positive cells
from the total number of cells. In addition, images of the
test specimen and control were printed. The number of
invading cells was counted and the distance of each cell
was calculated from a circle drawn at the circumference of
the spheroid. The distances were measured by drawing the
shortest straight line from the circle around the spheroid
to the invading cells. The measurements are in cm, but do
not represent true distance of invasion (due to magnifica-
tion of the image printed), but rather represent an [arbi-
trary unit] by which distances of the cells from the two
MTS, i.e. 14T specimen versus control, can be compared.BMC Medical Imaging 2008, 8:3 http://www.biomedcentral.com/1471-2342/8/3
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Results
Magnetic resonance microscopy of MTS in collagen I gel
Prior to imaging the MTS, we characterized the r1 relaxivity
(longitudinal relaxivity) of Gd-DTPA at 14T and the SNR
improvement after adding 10 mM Gd-DTPA into the col-
lagen I gel that did not contain any tumor cells. Table 1
shows that with 10 mM Gd-DTPA, we were able to reduce
the T1 relaxation time of the collagen gel from around
3000 ms to about 24 ms. The imaging time was reduced
from 10 hours to 3 hours with a two-fold increase of SNR
(from 20 to over 40).
The original MRM images of the MTS specimen are shown
in Figure 1. The time series clearly documents the growth
of the spheroid from different angles and at different
planes. Even with the 2D view, MRM showed different
patterns of cellular growth. Images on the left in Figure 1
show cells growing attached to the main body (red circle);
while those on the right show some cells seemingly mov-
ing away from the main spheroid. It becomes apparent
that with reduced imaging time and increased SNR, MRM
can indeed monitor the spatio-temporal expansion of an
MTS system.
Segmentation and 3D visualization of MTS
The 3D reconstruction shows rather heterogeneous
expansion patterns with rough surface growth areas
throughout over the course of the observation period (Fig-
ure 2(A)). Intriguingly, once started (orange droplets at
the MTS' proximal apex at time point '3 hours') glioma
cell expansion into the gel seems to give rise to an
'imprinting' process which confirms the 'trailblazer' con-
cept that has been described previously in [2,4]. Finally,
corresponding to the MTS' preserved structural viability
(compare with Fig. 3) Figure 2(B) also confirms its func-
tionality in that both MTS volume and surface area
increase throughout the observation period.
Histopathology
To semi-quantitatively evaluate the viability of the MTS
that has been imaged over 12 hours with 14T MRM,
standard immunohistochemistry was performed and the
histopathology results were compared with the control (as
described above). As documented in Figure 3, the imaged
MTS not only remains viable overall but, compared to the
control tumors the 14T specimen even contained a sub-
stantially larger proliferative fraction (see Table 2). More
specifically, the MIB-1 labeling index for the control is
12.5% (30 positive cells out of 239 counted) as compared
to the MIB-1 labeling index for the specimen which is with
21.1% (50 positive cells out of 236 cells counted) almost
doubled. Furthermore, reviewing comparable sections, in
the 14T specimen only 5 cells could be found to invade
the gel; conversely, a [total] of 32 cells invaded the colla-
gen matrix in the control experiment. While the min-max
values expectedly (given the difference in n) showed con-
siderably more heterogeneity in the control group,
intriguingly, the overall mean invasion distance was with
2.10 versus 2.11 almost identical between 14T specimen
and control. We note that a 2nd control experiment con-
firmed the results.
Discussion
Our data provide clear evidence that magnetic resonance
microscopy can be used to study the dynamic growth of
multi-cellular tumor spheroid embedded in a collagen I
matrix, at a resolution close to the single cell level (Figure
1). Adding 10 mM Gd- DTPA to the gel dramatically
reduced the image acquisition time without any detri-
mental impact on cell viability (Figure 3). Intriguingly,
the glioma cells showed distinct spatio-temporal expan-
sion patterns into the gel with spotty surface expansion
across the spheroid and the notion of a 'trailblazer' mech-
anism that guides cell motility in that single cells follow
each other along preformed pathways (Figure 2A). The
histological results showed surprisingly not only more
proliferative activity yet concomitantly also less cells pur-
suing invasion in the MRM specimen than in the control.
Intriguingly, the mean invasive distance was virtually
identical which supports the notion that the phenotype
itself remained unaffected. This preliminary data support
the notion of a "dichotomy" between proliferation and
migration, which was experimentally shown by Giese et
al. [19] and modeled with a molecular switching mecha-
nism by Athale et al [20] and Zhang et al [21]. The impact
of high field MR (14 Tesla in our study) on cancer cells is
somewhat controversial. For instance, Santini et al [22]
showed that a sinusoidal 50 Hz magnetic field of 1mT sig-
nificantly increased spheroid invasive properties, but had
no damage on growth. Short et al. [23] showed that for
the two cell lines exposed to a 4.7T field up to 72 hours,
there was no change in cell growth rate. On the contrary,
Table 1: MRI properties of Gd-DTPA and collagen I gel.
Gd-DTPA Collagen I Gel without 10 mM Gd Collagen I Gel with 10 mM Gd
r1 (1 mM-1 sec-1) 3.88 ± 0.12
R1 (sec-1) 0.33 42.32
SNR 16 42
Measured longitudinal relaxivity of Gd-DTPA at 14 T, corresponding R1 changes of collagen I gel after adding 10 mM Gd-DTPA, and the resulting 
SNR improvement.BMC Medical Imaging 2008, 8:3 http://www.biomedcentral.com/1471-2342/8/3
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Raylamn et al [24] demonstrated that human cancer cells
exposed to 11.7T for 64 hours had a slower growth rate. In
our study, the spheroid also experienced a high frequency
small magnetic field (B1 field, RF pulse) in addition to the
14T main magnetic field. Although the results from a sin-
gle case study must be interpreted with proper caution,
the increase in proliferation and concomitant reduction in
the number of invasive cells observed in our study may
indicate that different exposure time and magnetic field
strength can impact tumor expansion patterns. Hence, our
results warrant a more extended study to investigate in
detail the impact of MRM on normal and cancer cell via-
bility and phenotypes.
Kaufman et al [2] showed different patterns of MTS
growth and mobility in collagen I matrices of varying con-
centrations. They observed a more effective invasion in
high concentration (1.5 and 2.0 mg/mL) gels at early
time. The choice of 1.5 mg/mL concentration used here
was a compromise between having a high modulus to
maintain sample integrity and allowing cells to move
around quickly, and low optical density to allow us to
locate the spheroid easily by eye and enable, perhaps,
comparisons with optical imaging in the future. Previ-
ously, Brandl et al [25] used an 11.7T spectrometer to
study multicellular tumor spheroids that were generated
from human malignant MV3 melanoma. In their study,
the spheroid was allowed to grow for seven to fourteen
days in agar to a diameter of 400 – 1000 μm with a start-
ing dense population of 5·106 cells. This may lead to cen-
tral necrosis due to limited nutrition and oxygen in the
core region. They indeed observed a necrotic core in their
sample. The fact that the authors did not observe any mor-
phologic change over the four to five-hour imaging time
is less surprising since their agar environment is far more
rigid than the collagen I gel used in our study here.
The advantage of using MRM in this context lies in its non-
invasiveness, and its true three-dimensional full-scale
(global and local) view of MTS' dynamic growth. It is very
difficult, if not impossible to acquire whole three-dimen-
sion images of MTS in collagen I gel using most modern
optical imaging methods. Confocal microscopy allows
three-dimensional imaging; however, traditional single
photon reflectance or fluorescence methods are limited by
the working distance of objectives, typically a few hun-
dred microns. Two-photon confocal microscopy and sec-
ond harmonic generation can go beyond this limit, but
still remain within 1 mm of the surface [26-28]. Conven-
tional light microscopy can surpass this limitation as well,
but this is accompanied by a loss in axial resolution.
Moreover, a general limitation of light microscopy is that
it is constrained by the opacity of tissues. To overcome the
loss of signal due to increasing depth, one has two choices
– with clear drawbacks: i)  increasing light power may
decrease cell viability very quickly, together with the pho-
tobleaching seen in typical fluorescence imaging; ii) fixing
and staining the cells prior to imaging usually yields a bet-
ter signal-to-noise ratio than live cells, but the mere fact of
fixing the system is an obvious loss in evaluating the time
evolution of a living sample. That is not to say of course
that optical methods are incapable of generating useful
and quantitative information. Interesting studies by e.g.
Nygaard et al [29] and recent work by Kaufman et al [2]
yield useful information about MTS growth, though with
the limitations described above.
With the presently achieved MRM resolution already, we
observe "spotty" volumetric changes. Future studies of
MTS growth using MRM will reveal even more detailed
structural changes in a true 3D sense as the image resolu-
MRM images that show the MTS growth over time from dif- ferent angles Figure 1
MRM images that show the MTS growth over time 
from different angles. The images to the left depict the 
axial view, whereas those to the right show an arbitrary 
angle. These 2D images confirm the surface heterogeneity 
that emerges already 12 hrs post placement of the MTS into 
the gel, and depict a small group of invasive cells (images on 
the right) that can also be seen in Figures 2(A) and 3. On 
the other hand, images on the left demonstrate that certain 
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Volumetric rendering and growth dynamics of the MTS in the collagen I matrix at four consecutive time points Figure 2
Volumetric rendering and growth dynamics of the MTS in the collagen I matrix at four consecutive time 
points. (A) The segmented MTS is reconstructed in 3D and the color-coding indicates the growth increase at each time point. 
The MTS appears to grow anistropic, which may indicate regional heterogeneities in composition of either MTS or microenvi-
ronment, or both, and/or point towards a heterogeneous local interaction between cells and gel. (B) MTS volume and surface 
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tion further improves. MRM is beginning to bridge the
imaging scale that, until recently, has been accessible to
optical techniques only, with the clinical MRI data level
which is still plagued by a rather poor spatial and tempo-
ral resolution. Such three-dimensional volumetric studies
of the morphologic growth of MTS using MRM will pro-
vide complementary information about the growing
tumor and the dynamic interaction with its microenviron-
ment. With the help of integrative in silico modeling
insights gained with MRM in vitro can help us understand
better the complex cancer growth patterns seen in
patients.
Conclusion
We have shown that magnetic resonance microscopy can
be used to study dynamic tumor growth in vitro with a res-
olution that approaches that of light microscopy. Based
on this microscopic MRI pilot data, we argue that one may
be able to use this clinically relevant imaging modality
also in vitro, particularly once combined with molecular
imaging techniques. Being able to rely on one imaging
modality only, or even primarily, would greatly enhance
our ability to successfully integrate in vitro with in vivo
data, using innovative in silico models that bridge between
these scales.
Histopathology findings, comparing 14T MTS with control Figure 3
Histopathology findings, comparing 14T MTS with control. (A) H&E staining of 14T specimen (original magnification 
×100) showing only a small number of cells infiltrating the gel. Insert shows infiltrating cells in higher magnification (original 
magnification ×400). (B) MIB-1 immunostaining of 14T specimen (original magnification ×200), highlighting cells that are not in 
G0 as dark brown nuclei. (C) H&E staining of control (original magnification ×100) showing a large number of infiltrating cells 
in adjacent gel. Insert shows the infiltrating cells in higher magnification (original magnification ×400). (D) MIB-1 immunostain-
ing of control (original magnification ×200), highlighting cells that are not in G0 as dark brown nuclei.
Table 2: Histopathology.
Proliferation Invasion
14T 50 pos/236 21.1% n: 5 Mean: 2.10 SD: 2.07 Min-Max: 0.50–4.70
Control 30 pos/239 12.5% n: 32 Mean: 2.11 SD: 1.60 Min-Max: 0.30–6.50
To document proliferative activity, we report here the percentage of MIB-1 positive cells for the 14T specimen versus control. The invasion data 
result from measuring the straight-line distance between an invasive cell and a circle drawn around the spheroid. The measurements are done on a 
print of a 20× magnification, and represent [arbitrary units]. (See text for more details).BMC Medical Imaging 2008, 8:3 http://www.biomedcentral.com/1471-2342/8/3
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